Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Role of endomucin in angiogenesis and cytoskeletal organization
Author Affiliations & Notes
  • Jean Moon
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Zhengping Hu
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • John Fornagiel
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Patricia A D'Amore
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Jean Moon None; Zhengping Hu None; John Fornagiel None; Patricia D'Amore Sayht Therapeutics, LLC, Code O (Owner)
  • Footnotes
    Support  NH Grant EY026539; EY007145
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4989. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jean Moon, Zhengping Hu, John Fornagiel, Patricia A D'Amore; Role of endomucin in angiogenesis and cytoskeletal organization. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4989.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The endothelial glycocalyx, lining the apical surface of the endothelium, is involved in a host of vascular processes. The layer contains a network of membrane-bound proteoglycans and glycoproteins. One such glycoprotein is endomucin (EMCN), which our lab has revealed is a modulator of VEGFR2 function. Intravitreal injection of siEMCN into the eyes of P5 mice impairs vascular development. In vitro silencing of EMCN suppresses VEGF-induced proliferation and migration. Signaling pathways that drive cell migration converge on cytoskeletal remodeling. By coupling co-immunoprecipitation with liquid chromatography/mass spectrometry, we identified interactions between EMCN and proteins associated with actin cytoskeleton organization. The aim of the study is to investigate the influence of EMCN on cytoskeleton dynamics in angiogenesis.

Methods : The effects of EMCN were evaluated ex vivo using a choroidal explant sprouting assay and in vitro by phalloidin staining in human retinal endothelial cells (HRECs). Following AAV-mediated Cre deletion in choroidal punches isolated from EMCN-floxed mice, explants were maintained for six days. Angiogenesis was quantified by measuring the vascular sprouting area. To knockdown EMCN, HRECs were transfected with siRNA directed against human EMCN or non-targeting siRNA. Post-transfection, serum starved HRECs were stimulated with VEGF. To overexpress EMCN, cells were infected with adenovirus expressing myc-tagged EMCN. Actin was stained with phalloidin conjugated to Alexa Fluor 594. Analyses of sprouting area and mean fluorescence intensity were performed in ImageJ.

Results : The sprouting area was significantly reduced in choroidal explants with EMCN knockdown exposed to AAV-Cre (2.6±0.4 mm2) compared to tissues treated with AAV-GFP control (1.1±0.2 mm2). Western blot verified EMCN knockdown in HRECs. In the absence of VEGF, there were significantly lower absolute levels of F-actin. A comparable reduction in actin filaments was observed in siEMCN transfected cells stimulated with VEGF. Notably, overexpression of EMCN induced cell surface projections that coincided with an increased concentration of F-actin.

Conclusions : Loss of EMCN inhibited mouse choroidal sprouting, and EMCN expression correlated with formation of F-actin containing stress fibers. Our findings support further study of EMCN’s role in endothelial cell rearrangement and cell shape changes during angiogenesis.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×